| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272479A2 Novel compounds for enhancing chemotherapy |
| 01/08/2003 | EP1272477A1 Pyrimidine compounds |
| 01/08/2003 | EP1272469A1 Naphthalene derivatives and their pharmaceutical use |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272454A1 Method for synthesis of n- (s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
| 01/08/2003 | EP1272236A1 Methods and compositions for treating intervertebral disc degeneration |
| 01/08/2003 | EP1272225A2 Lipid-based systems for targeting diagnostic agents |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272222A2 Compositions for drug delivery |
| 01/08/2003 | EP1272221A2 Peptide conjugates for drug delivery |
| 01/08/2003 | EP1272219A1 New combination of a betablocker and a cholesterol-lowering agent |
| 01/08/2003 | EP1272218A2 A pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
| 01/08/2003 | EP1272209A1 Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases |
| 01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272195A1 Use of fulvestrant in the treatment of resistant breast cancer |
| 01/08/2003 | EP1272193A2 Synergistic methods and compositions for treating cancer |
| 01/08/2003 | EP1272191A2 An efficacious dosage regimen of galantamine that reduces side effects |
| 01/08/2003 | EP1272189A1 Inhibition of cyclooxygenase-2 activity |
| 01/08/2003 | EP1272188A2 Use of egfr tyrosine kinase inhibitors for treating bresta cancer |
| 01/08/2003 | EP1272187A1 Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system |
| 01/08/2003 | EP1272186A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 01/08/2003 | EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 01/08/2003 | EP1272184A2 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 01/08/2003 | EP1272180A1 Concentrated solutions of carvedilol |
| 01/08/2003 | EP1272176A1 Adamantyl derivatives as anti-cancer agents |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272174A1 Combination product comprising a non-steroidal antiandrogen and an egfr tyrosine kinase inhibitor |
| 01/08/2003 | EP1272173A1 Methods for inhibiting angiogenesis and tumor growth |
| 01/08/2003 | EP1272172A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1272166A2 Pharmaceutical compositions comprising fluvastatin |
| 01/08/2003 | EP1272161A2 Lipid-based drug delivery systems against parasitic infections |
| 01/08/2003 | EP1272160A2 Lipid-based drug delivery systems for topical application |
| 01/08/2003 | EP1272156A1 Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials |
| 01/08/2003 | EP1218407A4 Uses of kappa-conotoxin pviia |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP1098651B1 Novel urokinase inhibitors |
| 01/08/2003 | EP1087973B1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 01/08/2003 | EP1077945B1 Isoquinolines as urokinase inhibitors |
| 01/08/2003 | EP1066061A4 Use of scatter factor to enhance angiogenesis |
| 01/08/2003 | EP1023266B1 Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/08/2003 | EP0984934B1 Novel orally active iron (iii) chelators |
| 01/08/2003 | EP0983294B1 B-ring estratriene diol sulphates |
| 01/08/2003 | EP0973515B1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 01/08/2003 | EP0915881B1 Pyrroloazepine compounds |
| 01/08/2003 | EP0892795B1 Piperidinylpyramidine derivatives |
| 01/08/2003 | EP0833839B1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | EP0646012B1 WOUND HEALING AND TREATMENT OF FIBROTIC DISORDERS BY TGFbeta-3 |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390253A High order nucleic acid based structures |
| 01/08/2003 | CN1390233A Antitumor antibodies, proteins, and uses thereof |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390227A Enzyme catalyzed therapeutic activation |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/08/2003 | CN1390216A Polymorphsof crystalline (2-benzhycrryl-1-azabicyclo [2,2,2] oct-3-YC)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as NK-1 receptor antagonists |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390210A Process for preparing oxazolines from tetrahydrofurans |
| 01/08/2003 | CN1390206A Inhibitors of factor Xa |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390200A Inhibitors of metalloproteinases |
| 01/08/2003 | CN1390199A Prostaglandin derivatives |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1390143A Amphiphilic prodrugs |
| 01/08/2003 | CN1390142A Taxane prodrugs |
| 01/08/2003 | CN1390139A Oncolytic combinations for the treatment of cancer |
| 01/08/2003 | CN1390130A Glucosamine and egg for reducing inflammation |
| 01/08/2003 | CN1390129A Solutions containing epinastine |
| 01/08/2003 | CN1390125A High lipid diet |
| 01/08/2003 | CN1389265A Composite Chinese medicine with health care function |
| 01/08/2003 | CN1389263A Compound ginkgo capsule |
| 01/08/2003 | CN1389257A Cooling and heatstroke-eliminating tea and its prepn. |
| 01/08/2003 | CN1389250A Composite medicine for improving memory and intelligence |
| 01/08/2003 | CN1389222A Cerebral recuperating Hongyao essence for treating sequelae of cerebral concussion |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098263C Pyridin-2-yl-methylaminederivatives, method of preparing and application as medicine |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/08/2003 | CN1098243C Manufacture of tomato metabolite of carotenoid |
| 01/08/2003 | CN1098091C Oral liquid for invigorating brain and tonifying kidney |
| 01/08/2003 | CN1098088C Medicine for treating radiation or cerebroanoxia inadaptation |
| 01/08/2003 | CN1098073C Bee pollination inducing agent |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/07/2003 | US6504057 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/07/2003 | US6504034 Cell antiproliferative agents; anticancer agents |
| 01/07/2003 | US6504028 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/07/2003 | US6504022 Human bad polypeptides, encoding nucleic acids and methods of use |
| 01/07/2003 | US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503927 Amorphous paroxetine composition |
| 01/07/2003 | US6503920 Adminstering to treat progressive supranuclear palsy, Parkinson*s disease, and central nervous system disorders |